Comprehensive peptidomimetic libraries targeting protein-protein interactions

Accounts of Chemical Research

Volumn 45, Issue 10, 2012, Pages 1698-1709

  Whitby, Landon R ^a   Boger, Dale L ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 41; GP41 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; KAPPA OPIATE RECEPTOR; PEPTIDE; PEPTIDOMIMETIC AGENT; PROTEIN MDM2; PROTEIN P53;

ARTICLE; CHEMISTRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; PEPTIDE LIBRARY; PROTEIN ANALYSIS; PROTEIN SECONDARY STRUCTURE;

HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; PEPTIDE LIBRARY; PEPTIDES; PEPTIDOMIMETICS; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, SECONDARY; PROTO-ONCOGENE PROTEINS C-MDM2; RECEPTORS, OPIOID, KAPPA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84867511957     PISSN: 00014842     EISSN: 15204898     Source Type: Journal    
DOI: 10.1021/ar300025n     Document Type: Article

References (43)

1. Ou, H. D.; May, A. P.; O"Shea, C. C. The critical protein interactions and structures that elicit growth deregulation in cancer and viral replication Wiley Interdiscip. Rev.: Syst. Biol. Med. 2011, 3, 48-73
2. Zanzoni, A.; Soler-Lopez, M.; Aloy, P. A network medicine approach to human disease FEBS Lett. 2009, 583, 1759-1765
3. Arkin, M. R.; Wells, J. A. Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream Nat. Rev. Drug Discovery 2004, 3, 301-317 (Pubitemid 38499758)
4. Wells, J. A.; McClendon, C. L. Reaching for high-hanging fruit in drug discovery at protein-protein interfaces Nature 2007, 450, 1001-1009 (Pubitemid 350273630)
5. Moreira, I. S.; Fernandes, P. A.; Ramos, M. J. Hot spots - a review of the protein-protein interface determinant amino-acid residues Proteins 2007, 68, 803-812 (Pubitemid 47434705)
6. Kozakov, D.; Hall, D. R.; Chuang, G. Y.; Cencic, R.; Brenke, R.; Grove, L. E.; Beglov, D.; Pelletier, J.; Whitty, A.; Vajda, S. Structural conservation of druggable hot spots in protein-protein interfaces Proc. Natl. Acad. Sci. U.S.A. 2011, 108, 13528-13533
7. Eguchi, M.; Kahn, M. Design, synthesis, and application of peptide secondary structure mimetics Mini-Rev. Med. Chem. 2002, 2, 447-462
8. Meireles, L. M. C.; Mustata, G. Discovery of modulators of protein-protein interactions: current approaches and limitations Curr. Top. Med. Chem. 2011, 11, 248-257
9. Ko, E.; Liu, J.; Burgess, K. Minimalist and universal peptidomimetics Chem. Soc. Rev. 2011, 40, 4411-4421
10. Yin, H.; Hamilton, A. D. Protein secondary structure mimetics as modulators of protein-protein and protein-ligand interactions; Wiley-VCH Verlag: Weinheim, Germany, 2007; Vol. 1, pp 250-269.
11. Dewal, M. B.; Firestine, S. M. Non-peptidic α-helical mimetics as protein-protein interaction inhibitors Curr. Med. Chem. 2011, 18, 2420-2428
12. Ruiz-Gomez, G.; Tyndall, J. D.; Pfeiffer, B.; Abbenante, G.; Fairlie, D. P. Over one hundred peptide-activated G protein-coupled receptors recognize ligands with turn structure Chem. Rev. 2010, 110, PR1-PR41
13. Shaginian, A.; Whitby, L. R.; Hong, S.; Hwang, I.; Farooqi, B.; Searcey, M.; Chen, J.; Vogt, P. K.; Boger, D. L. Design, synthesis, and evaluation of an α-helix mimetic library targeting protein-protein interactions J. Am. Chem. Soc. 2009, 131, 5564-5572
14. Ambrus, G.; Whitby, L. R.; Singer, E. L.; Trott, O.; Choi, E.; Olson, A. J.; Boger, D. L.; Gerace, L. Small molecule peptidomimetic inhibitors of importin alpha/beta mediated nuclear transport Bioorg. Med. Chem. 2010, 18, 7611-7620
15. Whitby, L. R.; Ando, Y.; Setola, V.; Vogt, P. K.; Roth, B. L.; Boger, D. L. Design, synthesis, and validation of a β-turn mimetic library targeting protein-protein and peptide-receptor interactions J. Am. Chem. Soc. 2011, 133, 10184-10194
16. Boger, D. L.; Tarby, C. M.; Myers, P. L.; Caporale, L. H. Generalized dipeptidomimetic template: Solution phase parallel synthesis of combinatorial libraries J. Am. Chem. Soc. 1996, 118, 2109-2110 (Pubitemid 26100230)
17. Cheng, S.; Comer, D. D.; Williams, J. P.; Myers, P. L.; Boger, D. L. Novel solution phase strategy for the synthesis of chemical libraries containing small organic molecules J. Am. Chem. Soc. 1996, 118, 2567-2573 (Pubitemid 26130433)
18. Cheng, S.; Tarby, C. M.; Comer, D. D.; Williams, J. P.; Caporale, L. H.; Myers, P. L.; Boger, D. L. A solution-phase strategy for the synthesis of chemical libraries containing small organic molecules: A universal and dipeptide mimetic template Bioorg. Med. Chem. 1996, 4, 727-737 (Pubitemid 26170407)
19. Boger, D. L.; Desharnais, J.; Capps, K. Solution-phase combinatorial libraries: Modulating cellular signaling by targeting protein-protein or protein-DNA interactions Angew. Chem., Int. Ed. 2003, 42, 4138-4176 (Pubitemid 37168929)
20. Stover, J. S.; Shi, J.; Jin, W.; Vogt, P. K.; Boger, D. L. Discovery of inhibitors of aberrant gene transcription from libraries of DNA binding molecules: Inhibition of LEF-1 mediated gene transcription and oncogenic transformation J. Am. Chem. Soc. 2009, 131, 3342-3348
21. Boger, D. L.; Fink, B. E.; Brunette, S. R.; Tse, W. C.; Hedrick, M. P. A simple, high resolution method for establishing DNA binding affinity and sequence selectivity J. Am. Chem. Soc. 2001, 123, 5878-5891 (Pubitemid 32888456)
22. Bullock, B. N.; Jochim, A. L.; Arora, P. S. Assessing helical protein interfaces for inhibitor design J. Am. Chem. Soc. 2011, 133, 14220-14223
23. Ernst, J. T.; Becerril, J.; Park, H. S.; Yin, H.; Hamilton, A. D. Design and application of an α-helix-mimetic scaffold based on an oligoamide-foldamer strategy: antagonism of the Bak BH3/Bcl-xL complex Angew. Chem., Int. Ed. 2003, 42, 535-539 (Pubitemid 36232248)
24. Plante, J. P.; Burnley, T.; Malkova, B.; Webb, M. E.; Warriner, S. L.; Edwards, T. A.; Wilson, A. J. Oligobenzamide proteomimetic inhibitors of the p53-hDM2 protein-protein interaction Chem. Commun. 2009, 5091-5093
25. Lee, T.; Ahn, J. Solid-phase synthesis of tris-benzamides as α-helix mimetics ACS Comb. Sci. 2011, 13, 107-111
26. Shangary, S.; Wang, S. Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: A novel approach for cancer therapy Annu. Rev. Pharmacol. Toxicol. 2009, 49, 223-241
27. Kussie, P. H.; Gorina, S.; Marechal, V.; Elenbaas, B.; Moreau, J.; Levine, A. J.; Pavletich, N. P. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain Science 1996, 274, 948-953 (Pubitemid 26398409)
28. Chan, D. C.; Kim, P. S. HIV entry and its inhibition Cell 1998, 93, 681-684 (Pubitemid 28257575)
29. Chan, D. C.; Chutkowski, C. T.; Kim, P. S. Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 15613-15617 (Pubitemid 29018748)
30. Cai, L.; Jiang, S. Development of peptide and small-molecule HIV-1 fusion inhibitors that target gp41 ChemMedChem 2010, 5, 1813-1824
31. Horne, W. S.; Johnson, L. M.; Ketas, T. J.; Klasse, P. J.; Lu, M.; Moore, J. P.; Gellman, S. H. Structural and biological mimicry of protein surface recognition by α/β-peptide foldamers Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 14751-14756
32. Stephens, O. M.; Kim, S.; Welch, B. D.; Hodsdon, M. E.; Kay, M. S.; Schepartz, A. Inhibiting HIV fusion with a β-peptide foldamer J. Am. Chem. Soc. 2005, 127, 13126-13127 (Pubitemid 41377586)
33. Ernst, J. T.; Kutzki, O.; Debnath, A. K.; Jiang, S.; Lu, H.; Hamilton, A. D. Design of a protein surface antagonist based on α-helix mimicry: Inhibition of gp41 assembly and viral fusion Angew. Chem., Int. Ed. 2002, 41, 278-281 (Pubitemid 34118069)
34. Cai, L.; Gochin, M. A novel fluorescence intensity screening assay identifies new low-molecular-weight inhibitors of the gp41 coiled-coil domain of human immunodeficiency virus type 1 Antimicrob. Agents Chemother. 2007, 51, 2388-2395 (Pubitemid 47047315)
35. Whitby, L. R.; Boyle, K. E.; Cai, L.; Yu, X.; Gochin, M.; Boger, D. L. Discovery of HIV fusion inhibitors targeting gp41 using a comprehensive α-helix mimetic library Bioorg. Med. Chem. Lett. 2012, 22, 2861-2865
36. Garland, S. L.; Dean, P. M. Design criteria for molecular mimics of fragments of the β-turn. 1. C alpha atom analysis J. Comput.-Aided Mol. Des. 1999, 13, 469-483 (Pubitemid 29395562)
37. Eguchi, M. Recent advances in selective opioid receptor agonists and antagonists Med. Res. Rev. 2004, 24, 182-212 (Pubitemid 38230679)
38. Fichna, J.; Janecka, A.; Costentin, J.; Do Rego, J. C. The endomorphin system and its evolving neurophysiological role Pharmacol. Rev. 2007, 59, 88-123 (Pubitemid 46333997)
39. Tomboly, C.; Ballet, S.; Feytens, D.; Kover, K. E.; Borics, A.; Lovas, S.; Al-Khrasani, M.; Furst, Z.; Toth, G.; Benyhe, S.; Tourwe, D. Endomorphin-2 with a β-turn backbone constraint retains the potent μ-opioid receptor agonist properties J. Med. Chem. 2008, 51, 173-177
40. Eguchi, M.; Shen, R. Y.; Shea, J. P.; Lee, M. S.; Kahn, M. Design, synthesis, and evaluation of opioid analogues with non-peptidic β-turn scaffold: Enkephalin and endomorphin mimetics J. Med. Chem. 2002, 45, 1395-1398 (Pubitemid 34246101)
41. Boger, D. L.; Fink, B. E.; Hedrick, M. P. Total synthesis of distamycin A and 2640 analogues: A solution-phase combinatorial approach to the discovery of new, bioactive DNA binding agents and development of a rapid, high-throughput screen for determining relative DNA binding affinity or DNA binding sequence selectivity J. Am. Chem. Soc. 2000, 122, 6382-6394 (Pubitemid 30481737)
42. Boger, D. L.; Sato, H.; Lerner, A. E.; Austin, B. J.; Patterson, J. E.; Patricelli, M. P.; Cravatt, B. F. Trifluoromethyl ketone inhibitors of fatty acid amide hydrolase: A probe of structural and conformational features contributing to inhibition Bioorg. Med. Chem. Lett. 1999, 9, 265-270 (Pubitemid 29059542)
43. Otrubova, K.; Boger, D. L. α-Ketoheterocycle-based inhibitors of fatty acid amide hydrolase (FAAH) ACS Chem. Neurosci. 2012, 3, 340-348